Clinical Trial Update: A Study in Chinese Patients With Acquired Blepharoptosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Chinese patients with acquired blepharoptosis is currently recruiting, sponsored by Santen Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoptosis

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Blepharoptosis | Phase 3 | Status: RECRUITING